CASP2 and hairy cell leukemia: Reduced caspase-2 protein levels have also been reported in a meta-analysis of published data sets for Burkitt lymphoma (BL), mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL) and hairy cell leukemia [23, 25].